Articles published by Travere Therapeutics, Inc.
Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023
October 13, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 11, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)
September 26, 2023
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 11, 2023
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
February 28, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Announces Proposed Public Offering of Common Stock
February 27, 2023
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.